Massachusetts 2023-2024 Regular Session

Massachusetts Senate Bill S2492

Introduced

10/30/23

Refer

10/30/23

Report Pass

11/9/23

Caption

Relative to pharmaceutical access, costs and transparency

Latest MA S2492 Activity

View All Events: MA 2023-2024 Regular Session S2492

Companion Bills

MA S749

Similar To Relative to pharmaceutical access, costs and transparency

MA S2520

Similar To Relative to pharmaceutical access, costs and transparency

MA S2499

Replaced by Relative to pharmaceutical access, costs and transparency

MA S732

Replaces Relative to promoting comprehensive transparency in the pharmaceutical industry

Previously Filed As

MA S3012

Relative to pharmaceutical access, costs and transparency

MA S2499

Relative to pharmaceutical access, costs and transparency

MA S749

Relative to pharmaceutical access, costs and transparency

MA S2520

Relative to pharmaceutical access, costs and transparency

MA S895

To promote transparency and prevent price gouging of pharmaceutical drug prices

MA S783

To promote transparency and prevent price gouging of pharmaceutical drug prices

MA H7116

Pharmaceutical Cost Transparency

MA H5079

Pharmaceutical Cost Transparency

MA H1176

Relative to promoting comprehensive transparency in the pharmaceutical industry

MA S732

Relative to promoting comprehensive transparency in the pharmaceutical industry

Similar Bills

MA S749

Relative to pharmaceutical access, costs and transparency

MA H945

To ensure prescription drug cost transparency and affordability

MA H1215

Relative to pharmacy benefit managers

MA H4910

Similar Bills

MA S2499

Relative to pharmaceutical access, costs and transparency

MA H4891

Similar Bills

MA S2520

Relative to pharmaceutical access, costs and transparency

MA S783

To promote transparency and prevent price gouging of pharmaceutical drug prices